Cargando…

Contractile Activity of Myotubes Derived from Human Induced Pluripotent Stem Cells: A Model of Duchenne Muscular Dystrophy

Duchenne muscular dystrophy (DMD) is a genetic disorder that results from deficiency of the dystrophin protein. In recent years, DMD pathological models have been created using induced pluripotent stem (iPS) cells derived from DMD patients. In addition, gene therapy using CRISPR-Cas9 technology to r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshioka, Kantaro, Ito, Akira, Horie, Masanobu, Ikeda, Kazushi, Kataoka, Sho, Sato, Keiichiro, Yoshigai, Taichi, Sakurai, Hidetoshi, Hotta, Akitsu, Kawabe, Yoshinori, Kamihira, Masamichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534131/ https://www.ncbi.nlm.nih.gov/pubmed/34685536 http://dx.doi.org/10.3390/cells10102556

Ejemplares similares

A muscle fatigue-like contractile decline was recapitulated using skeletal myotubes from Duchenne muscular dystrophy patient-derived iPSCs
por: Uchimura, Tomoya, et al.
Publicado: (2021)

Genome Editing Gene Therapy for Duchenne Muscular Dystrophy
por: Hotta, Akitsu
Publicado: (2015)

Improved contractile force generation of tissue-engineered skeletal muscle constructs by IGF-I and Bcl-2 gene transfer with electrical pulse stimulation
por: Ikeda, Kazushi, et al.
Publicado: (2016)

In vitro drug testing based on contractile activity of C2C12 cells in an epigenetic drug model
por: Ikeda, Kazushi, et al.
Publicado: (2017)

Cellular Reprogramming, Genome Editing, and Alternative CRISPR Cas9 Technologies for Precise Gene Therapy of Duchenne Muscular Dystrophy
por: Gee, Peter, et al.
Publicado: (2017)

Efficacy of Prednisolone in Generated Myotubes Derived From Fibroblasts of Duchenne Muscular Dystrophy Patients
por: Kameyama, Tsubasa, et al.
Publicado: (2018)

Precise Correction of the Dystrophin Gene in Duchenne Muscular Dystrophy Patient Induced Pluripotent Stem Cells by TALEN and CRISPR-Cas9
por: Li, Hongmei Lisa, et al.
Publicado: (2014)

Orai1–STIM1 Regulates Increased Ca(2+) Mobilization, Leading to Contractile Duchenne Muscular Dystrophy Phenotypes in Patient-Derived Induced Pluripotent Stem Cells
por: Uchimura, Tomoya, et al.
Publicado: (2021)

The heart in Duchenne muscular dystrophy: early detection of contractile performance alteration
por: Wagner, Sören, et al.
Publicado: (2012)

A human in vitro model of Duchenne muscular dystrophy muscle formation and contractility
por: Nesmith, Alexander P., et al.
Publicado: (2016)

Establishment of quantitative and consistent in vitro skeletal muscle pathological models of myotonic dystrophy type 1 using patient-derived iPSCs
por: Kawada, Ryu, et al.
Publicado: (2023)

Novel cell lines derived from Chinese hamster kidney tissue
por: Kawabe, Yoshinori, et al.
Publicado: (2022)

Short (16-mer) locked nucleic acid splice-switching oligonucleotides restore dystrophin production in Duchenne Muscular Dystrophy myotubes
por: Pires, Vanessa Borges, et al.
Publicado: (2017)

A patient-derived iPSC model revealed oxidative stress increases facioscapulohumeral muscular dystrophy-causative DUX4
por: Sasaki-Honda, Mitsuru, et al.
Publicado: (2018)

A new immunodeficient Duchenne muscular dystrophy rat model to evaluate engraftment after human cell transplantation
por: Sato, Masae, et al.
Publicado: (2023)

Magnetic heating of nanoparticles as a scalable cryopreservation technology for human induced pluripotent stem cells
por: Ito, Akira, et al.
Publicado: (2020)

HepG2-Based Designer Cells with Heat-Inducible Enhanced Liver Functions
por: Kitano, Hiroyuki, et al.
Publicado: (2022)

Tamoxifen treatment ameliorates contractile dysfunction of Duchenne muscular dystrophy stem cell-derived cardiomyocytes on bioengineered substrates
por: Birnbaum, Foster, et al.
Publicado: (2022)

Transplantation of human iPSC-derived muscle stem cells in the diaphragm of Duchenne muscular dystrophy model mice
por: Miura, Yasutomo, et al.
Publicado: (2022)

Cellular senescence-mediated exacerbation of Duchenne muscular dystrophy
por: Sugihara, Hidetoshi, et al.
Publicado: (2020)

Survival in Duchenne muscular dystrophy
por: RALL, SUSANNE, et al.
Publicado: (2012)

Theragnosis for Duchenne Muscular Dystrophy
por: Luce, Leonela, et al.
Publicado: (2021)

Left Ventricular End-Diastolic Diameter and Cardiac Mortality in Duchenne Muscular Dystrophy
por: Segawa, Kazuhiko, et al.
Publicado: (2020)

In vitro exercise model using contractile human and mouse hybrid myotubes
por: Chen, Weijian, et al.
Publicado: (2019)

Human Skeletal Muscle Cells Derived from the Orbicularis Oculi Have Regenerative Capacity for Duchenne Muscular Dystrophy
por: Yamanaka, Yukito, et al.
Publicado: (2019)

Early pathogenesis of Duchenne muscular dystrophy modelled in patient-derived human induced pluripotent stem cells
por: Shoji, Emi, et al.
Publicado: (2015)

Prednisolone Attenuates Improvement of Cardiac and Skeletal Contractile Function and Histopathology by Lisinopril and Spironolactone in the mdx Mouse Model of Duchenne Muscular Dystrophy
por: Janssen, Paul M. L., et al.
Publicado: (2014)

The Angiotensin Converting Enzyme Inhibitor Lisinopril Improves Muscle Histopathology but not Contractile Function in a Mouse Model of Duchenne Muscular Dystrophy
por: Lowe, Jeovanna, et al.
Publicado: (2015)

Hypokalemia complicating Duchenne muscular dystrophy.
por: McDonald, B., et al.
Publicado: (1987)

The role of fibrosis in Duchenne muscular dystrophy
por: KLINGLER, WERNER, et al.
Publicado: (2012)

Delay in Diagnosis of Duchenne Muscular Dystrophy
por: Rao, Vamshi K., et al.
Publicado: (2015)

Circulating Biomarkers for Duchenne Muscular Dystrophy
por: Aartsma-Rus, Annemieke, et al.
Publicado: (2015)

Targeting angiogenesis in Duchenne muscular dystrophy
por: Podkalicka, Paulina, et al.
Publicado: (2019)

Regenerative biomarkers for Duchenne muscular dystrophy
por: Guiraud, Simon, et al.
Publicado: (2019)

Eteplirsen in the treatment of Duchenne muscular dystrophy
por: Lim, Kenji Rowel Q, et al.
Publicado: (2017)

Nutritional Challenges in Duchenne Muscular Dystrophy
por: Salera, Simona, et al.
Publicado: (2017)

Lifetime Care of Duchenne Muscular Dystrophy
por: MacKintosh, Erin W., et al.
Publicado: (2020)

The Duchenne muscular dystrophy gene and cancer
por: Jones, Leanne, et al.
Publicado: (2020)

CRISPR Therapeutics for Duchenne Muscular Dystrophy
por: Erkut, Esra, et al.
Publicado: (2022)

Exon-Skipping in Duchenne Muscular Dystrophy
por: Takeda, Shin’ichi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5b3ei9j4800o819n275lfonqi3